ResearcherKaiser PermanenteActive in the last 2 years

Maoen Pan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3837-5927; OpenAlex author ID A5056036743. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 4

The combined effect of hypoxia activation and radiosensitization by a multifunctional nanoplatform system enhances the therapeutic efficacy of chemoradiotherap… Co-author DOI 10.1016/j.pan.2024.11.003 ↗
Photothermal augment stromal disrupting effects for enhanced Abraxane synergy chemotherapy in pancreatic cancer PDX mode. Co-author DOI 10.1039/d0bm00549e ↗
Overall survival in patients with metastatic pancreatic cancer after surgically primary tumor resected: a SEER-based nomogram analysis Co-author DOI 10.21203/rs.2.23955/v1 ↗
WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC. Co-author DOI 10.1186/s13046-018-0848-6 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ronggui Lin · 2 shared papers, 2020–2024 · strength 0.40
- Paper The combined effect of hypoxia activation and radiosensitization by a multifunctional nanoplatform system enhances the … DOI 10.1016/j.pan.2024.11.003 ↗
- Paper Photothermal augment stromal disrupting effects for enhanced Abraxane synergy chemotherapy in pancreatic cancer PDX mod… DOI 10.1039/d0bm00549e ↗
Heguang Huang · 2 shared papers, 2020–2024 · strength 0.40
- Paper The combined effect of hypoxia activation and radiosensitization by a multifunctional nanoplatform system enhances the … DOI 10.1016/j.pan.2024.11.003 ↗
- Paper Photothermal augment stromal disrupting effects for enhanced Abraxane synergy chemotherapy in pancreatic cancer PDX mod… DOI 10.1039/d0bm00549e ↗
Heguang Huang · 2 shared papers, 2018–2020 · strength 0.25
- Paper Overall survival in patients with metastatic pancreatic cancer after surgically primary tumor resected: a SEER-based no… DOI 10.21203/rs.2.23955/v1 ↗
- Paper WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PD… DOI 10.1186/s13046-018-0848-6 ↗
Xianchao Lin · 2 shared papers, 2018–2020 · strength 0.20
- Paper Photothermal augment stromal disrupting effects for enhanced Abraxane synergy chemotherapy in pancreatic cancer PDX mod… DOI 10.1039/d0bm00549e ↗
- Paper WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PD… DOI 10.1186/s13046-018-0848-6 ↗
Tianhong Teng · 1 shared paper, 2020 · strength 0.12
- Paper Photothermal augment stromal disrupting effects for enhanced Abraxane synergy chemotherapy in pancreatic cancer PDX mod… DOI 10.1039/d0bm00549e ↗
Yu Pan · 1 shared paper, 2018 · strength 0.09
- Paper WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PD… DOI 10.1186/s13046-018-0848-6 ↗
Minggui Pan · 1 shared paper, 2018 · strength 0.09
- Paper WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PD… DOI 10.1186/s13046-018-0848-6 ↗
Fengchun Lu · 1 shared paper, 2018 · strength 0.09
- Paper WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PD… DOI 10.1186/s13046-018-0848-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.